Abstract: The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

Abstract: An engaging mechanism, a transmission dock equipped with the same, and an electronic apparatus having the same are provided. The engaging mechanism includes a rotary fastening element, a guiding frame and a translating frame. The rotary fastening element rotates about an axis to reach an engaging state. The guiding frame has two opposing outer sidewalls and is protrudingly disposed on a support surface of the transmission dock. The axis is substantially parallel to the support surface. The rotary fastening element protrudes from one of the outer sidewalls in the engaging state. The translating frame has two opposing inner sidewalls and two opposing upper wall surfaces. The two outer sidewalls are disposed between the two inner sidewalls, allowing the rotary fastening element to rotate and reach the engaging state and thereby stop one of the upper wall surfaces, when the translating frame connects with the support surface.

Abstract: The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

Abstract: The present invention provides a transmission base and an electronic apparatus. The transmission base is for receiving a side portion of a first unit of the electronic apparatus. The first unit includes a first battery. The transmission base includes a first wall portion and a second wall portion. The first wall portion and the second wall portion support the side portion. The first wall portion includes a matching structure, which is matched and assembled with a fitting structure of the first battery. When the matching structure of the first wall portion is matched and assembled with the fitting structure, the first unit is electrically connected to the transmission base; when the second wall portion is in contact with the fitting structure, the first unit is non-electrically connected to the transmission base.

Abstract: The present disclosure describes a method of forming a dielectric layer or a dielectric stack on a photoresist layer while minimizing or avoiding damage to the photoresist. In addition, the dielectric layer or dielectric stack can till high-aspect ratio openings and can be removed with etching. The dielectric layer or dielectric stack can be deposited with a conformal, low-temperature chemical vapor deposition process or a conformal, low-temperature atomic layer deposition process that utilizes a number of precursors and plasmas or reactant gases.

Abstract: An oven controlled crystal oscillator consisting of heater-embedded ceramic package includes a substrate, a crystal package, a crystal blank, a metal lid, a first IC chip, and a cover lid. The crystal package is mounted on the substrate, and a central bottom of the crystal package is provided with the first IC chip. The crystal blank is mounted in the crystal package and sealed by the metal lid. The crystal package has an embedded heater layer establishing a symmetric thermal field with respect to the first IC chip and the crystal blank. Alternatively, a heater-embedded ceramic carrier substrate is arranged between the first IC chip and the crystal blank to establish a symmetric thermal field with respect to the first IC chip and the crystal blank. The cover lid is combined with the substrate to cover the crystal package and the metal lid.

Abstract: The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

Abstract: An oven controlled crystal oscillator consisting of heater-embedded ceramic package includes a substrate, a crystal package, a crystal blank, a metal lid, a first IC chip, and a cover lid. The crystal package is mounted on the substrate, and a central bottom of the crystal package is provided with the first IC chip. The crystal blank is mounted in the crystal package and sealed by the metal lid. The crystal package has an embedded heater layer establishing a symmetric thermal field with respect to the first IC chip and the crystal blank. Alternatively, a heater-embedded ceramic carrier substrate is arranged between the first IC chip and the crystal blank to establish a symmetric thermal field with respect to the first IC chip and the crystal blank. The cover lid is combined with the substrate to cover the crystal package and the metal lid.

Abstract: An electronic device includes an antenna, a wireless transmitter, a proximity sensor and a controller. The antenna includes a first radiating element and a second radiating element which has a different length than the first radiating element. The wireless transmitter is to send a radio signal to the antenna and the controller is to disable the first radiating element in response to the proximity sensor detecting a body part.

Abstract: The present invention discloses a method for prognosing and reducing cardiovascular diseases in patients with kidney diseases, comprising obtaining a bio-sample of a healthy person and a bio-sample of a patient with kidney disease, detecting the expression of specific lncRNA biomarkers individually, such as one or more combinations of DKFZP434I0714, KCNJ2AS1, LOC256880, LOC644656, FAM86FP, FAM66D, LOC100289511, and HTR7P1, comparing the expressions between the samples of the healthy persons and the samples of the patients with kidney diseases to obtain a ratio, and prognosing whether the patients with kidney diseases belong to a high-risk group to have cardiovascular diseases based on the ratio. Furthermore, the method reduces the possibility of patients with kidney diseases to have cardiovascular diseases through the inhibition technology.

Abstract: An engaging mechanism, a transmission dock equipped with the same, and an electronic apparatus having the same are provided. The engaging mechanism includes a rotary fastening element, a guiding frame and a translating frame. The rotary fastening element rotates about an axis to reach an engaging state. The guiding frame has two opposing outer sidewalls and is protrudingly disposed on a support surface of the transmission dock. The axis is substantially parallel to the support surface. The rotary fastening element protrudes from one of the outer sidewalls in the engaging state. The translating frame has two opposing inner sidewalls and two opposing upper wall surfaces. The two outer sidewalls are disposed between the two inner sidewalls, allowing the rotary fastening element to rotate and reach the engaging state and thereby stop one of the upper wall surfaces, when the translating frame connects with the support surface.

Abstract: A method of manufacturing a semiconductor device includes depositing a dielectric layer over a substrate, performing a first patterning to form an opening in the dielectric layer, and depositing an oxide film over and contacting the dielectric layer and within the opening in the dielectric layer. The oxide film is formed from multiple precursors that are free of O2, and depositing the oxide film includes forming a plasma of a first precursor of the multiple precursors.

Abstract: The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

Abstract: A method for early diagnosis and treatment of acute coronary syndrome (ACS) in a subject, which measures a level of at least one specific circulating biomarker using immunomagnetic reduction, e.g. FABP4, in the subject within a certain time period after onset of at least one symptom of ACS and administers guideline recommended therapies including early reperfusion therapy and effective drugs to the subject who is observed to have significant dynamic changes in the level of the at least one specific biomarker.

Abstract: The present disclosure describes a method of forming a dielectric layer or a dielectric stack on a photoresist layer while minimizing or avoiding damage to the photoresist. In addition, the dielectric layer or dielectric stack can till high-aspect ratio openings and can be removed with etching. The dielectric layer or dielectric stack can be deposited with a conformal, low-temperature chemical vapor deposition process or a conformal, low-temperature atomic layer deposition process that utilizes a number of precursors and plasmas or reactant gases.

Abstract: A lock package is provided. The package holder is suitable to simultaneously position at least two locks. The package holder includes a plate portion and a partition. The plate portion has two opposite surfaces, at least two positioning portions, and a non-positioning portion. The surfaces are configured to be disposed with the locks. The positioning portions are configured to position plural escutcheons of the locks, and a portion of each of the escutcheons is exposed, in which the non-positioning portion is configured to cover a plurality of handles of the locks.

Abstract: The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

Abstract: The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

Abstract: The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

Abstract: A method for prognosing adverse cardiovascular events or deaths in patients with coronary artery diseases, includes the steps of selecting at least one target long non-coding RNA from the group comprising lnc-CXXC11-1:2, lnc-CCT7-1:1, LINC00930:1, TSC22D1-AS1:3, lnc-MEGF10-6:1, lnc-INA-1:1, HPN-AS1:2, lnc-TFAP4-3:1, lnc-SCN8A-2:2, lnc-NCF1-1, BRE-AS1, lnc-ZFAT-6, lnc-SLC46A3-5, lnc-CXCL3-2, lnc-AL137798.1-8, lnc-BCL2L2-PABPN1-1, and lnc-EBF3-4, analyzing the at least one target long non-coding RNA in a sample from a patients with coronary artery diseases, and utilizing the expression as a predictor for adverse cardiovascular events or deaths in patients with coronary artery diseases.